Q1 Earnings Estimate for Penumbra Issued By Leerink Partnrs

Penumbra, Inc. (NYSE:PEN) – Equities researchers at Leerink Partnrs decreased their Q1 2025 EPS estimates for shares of Penumbra in a research report issued to clients and investors on Tuesday, February 18th. Leerink Partnrs analyst M. Kratky now anticipates that the company will post earnings of $0.69 per share for the quarter, down from their previous estimate of $0.83. The consensus estimate for Penumbra’s current full-year earnings is $3.86 per share. Leerink Partnrs also issued estimates for Penumbra’s Q2 2025 earnings at $0.83 EPS, FY2025 earnings at $3.61 EPS and FY2026 earnings at $5.54 EPS.

PEN has been the topic of a number of other research reports. StockNews.com raised shares of Penumbra from a “hold” rating to a “buy” rating in a research report on Thursday. JPMorgan Chase & Co. lifted their price objective on shares of Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research report on Wednesday. Needham & Company LLC reaffirmed a “hold” rating on shares of Penumbra in a research report on Wednesday. Piper Sandler reaffirmed an “overweight” rating and issued a $330.00 price objective (up previously from $250.00) on shares of Penumbra in a research report on Wednesday. Finally, UBS Group lifted their price objective on shares of Penumbra from $305.00 to $320.00 and gave the stock a “buy” rating in a research report on Wednesday. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Penumbra currently has a consensus rating of “Moderate Buy” and a consensus price target of $292.64.

Penumbra Trading Down 3.5 %

NYSE:PEN opened at $292.52 on Friday. The firm has a 50-day simple moving average of $258.16 and a 200-day simple moving average of $227.04. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01. Penumbra has a one year low of $148.00 and a one year high of $310.00. The firm has a market cap of $11.27 billion, a P/E ratio of 860.35, a P/E/G ratio of 2.23 and a beta of 0.53.

Penumbra (NYSE:PEN) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.88 by $0.09. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The business had revenue of $315.52 million during the quarter, compared to analyst estimates of $311.63 million.

Institutional Trading of Penumbra

Large investors have recently made changes to their positions in the business. China Universal Asset Management Co. Ltd. acquired a new position in shares of Penumbra in the 4th quarter valued at $573,000. State Street Corp lifted its stake in shares of Penumbra by 0.3% in the 3rd quarter. State Street Corp now owns 1,236,671 shares of the company’s stock valued at $240,298,000 after purchasing an additional 3,863 shares during the period. Thrivent Financial for Lutherans lifted its stake in shares of Penumbra by 3,832.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 368,298 shares of the company’s stock valued at $71,564,000 after purchasing an additional 358,932 shares during the period. E. Ohman J or Asset Management AB lifted its stake in shares of Penumbra by 10.4% in the 4th quarter. E. Ohman J or Asset Management AB now owns 21,312 shares of the company’s stock valued at $5,061,000 after purchasing an additional 2,000 shares during the period. Finally, AlphaCentric Advisors LLC acquired a new position in shares of Penumbra in the 3rd quarter valued at $777,000. 88.88% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Adam Elsesser sold 15,000 shares of the company’s stock in a transaction on Friday, December 20th. The shares were sold at an average price of $242.96, for a total value of $3,644,400.00. Following the sale, the chief executive officer now directly owns 837,582 shares of the company’s stock, valued at $203,498,922.72. This represents a 1.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $244.49, for a total transaction of $146,694.00. Following the completion of the sale, the executive vice president now directly owns 63,444 shares in the company, valued at $15,511,423.56. This trade represents a 0.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,219 shares of company stock valued at $4,426,439 in the last ninety days. Insiders own 5.00% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.